signumia
Data is being collected. The dashboard will appear when it is available.
SYMBOL
Data is being collected. The dashboard will appear when it is available.
CVS

Close price

$101.87

Latest price

$103.86

Change vs close

+1.95%

Current price: $103.86

Market cap

132.52B

Pre-market and after-hours data may be partial or delayed depending on the source and licensing.

CVS Health Corporation

CVS

NYSE · Consumer Staples · Retail-Drug Stores and Proprietary Stores

Company Profile

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Website

https://www.cvshealth.com

Country

RI

Sector

Consumer Staples

Industry

Retail-Drug Stores and Proprietary Stores

CIK

0000064803

Candlestick Chart

1D · Data source: loading

Loading candle data

Quarterly Performance Snapshot

Actual revenue and net income based on quarterly filings

Q2 Jul 2026

Quarterly Snapshot

Q2 Jul 2026

Mix

235.95B

Market cap

56.16%

132.52B

Expected quarterly revenue

42.84%

101.07B

Estimated quarterly net income

1%

2.36B

Market cap / expected revenue

1.31x

Revenue

Forecast

101.07B

Previous quarter

+0.64%

Net income

Forecast

2.36B

Previous quarter

-19.87%

Revenue and Net Income Trend

RevenueNet income

Quarterly Performance

13 quarters

Financial Statements

SEC Filings

12 filings shown

Open the original SEC filings to view the full document.

FormFiling DateReport DateAccessionLink
11-KJun 23, 2026Dec 31, 20250000064803-26-000090Document
4Jun 1, 2026May 31, 20260000064803-26-000088Document
4Jun 1, 2026May 31, 20260000064803-26-000086Document
4May 22, 2026May 20, 20260000064803-26-000084Document
144May 22, 2026No data0001224983-26-000006Document
S-8May 22, 2026No data0001193125-26-236998Document
S-3ASRMay 22, 2026No data0001193125-26-236988Document
4May 21, 2026May 19, 20260000905148-26-002617Document
144May 21, 2026No data0001949846-26-000310Document
8-KMay 18, 2026May 14, 20260000064803-26-000082Document
4May 15, 2026May 14, 20260000064803-26-000080Document
4May 15, 2026May 14, 20260000064803-26-000078Document

Latest News

12 articles
ZacksJun 25, 2026, 12:00 AMnasdaq

Can Cigna's Expansion Beyond Health Insurance Fuel Long-Term Growth?

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

Open article
The Motley FoolJun 22, 2026, 12:00 AMnasdaq

Why CVS Stock Trounced the Market Today

Key PointsIt is to start participating in a Medicare discount program for such medications, among other measures.

Open article
ZacksJun 19, 2026, 12:00 AMnasdaq

CVS Health (CVS) is a Great Momentum Stock: Should You Buy?

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Open article
The Motley FoolJun 16, 2026, 12:00 AMnasdaq

CVS Health's Comeback Is Just Getting Started -- and Its Valuation Still Looks Shockingly Cheap

Key PointsCVS Health's financial results are improving due to several initiatives.

Open article
The Motley FoolJun 15, 2026, 12:00 AMnasdaq

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock?

Key PointsEarlier this month, Mizuho's Ann Hynes raised her price target to $115 per share.

Open article
ZacksJun 15, 2026, 12:00 AMnasdaq

Zacks.com featured highlights include StoneCo, USANA Health, Strategic Education, Nexa Resources and CVS

STNE, USNA, STRA, NEXA and CVS are highlighted as low price-to-book stocks with solid growth projections and strong value scores.

Open article
ZacksJun 12, 2026, 12:00 AMnasdaq

MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term Stability

Molina Healthcare secures an Illinois Medicaid managed care contract starting in 2027, reinforcing its position in a key market and supporting long-term growth.

Open article
ZacksJun 12, 2026, 12:00 AMnasdaq

Danaher Boosts Product Portfolio With the Acquisition of Masimo

DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.

Open article
ZacksJun 12, 2026, 12:00 AMnasdaq

5 Low Price-to-Book Stocks That Are Worth Buying in June

STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.

Open article
ZacksJun 11, 2026, 12:00 AMnasdaq

Strong Performance Continues at DHR's Biotechnology Unit: What's Next?

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.

Open article
ZacksJun 8, 2026, 12:00 AMnasdaq

Has CVS Health (CVS) Outpaced Other Medical Stocks This Year?

Here is how CVS Health (CVS) and Align Technology (ALGN) have performed compared to their sector so far this year.

Open article
BarchartJun 5, 2026, 12:00 AMnasdaq

Stocks Rebound on Strength in Banks and Managed Healthcare

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. June E-mini S&P futures (ESM26 ) rose +0.36%, and June E-mini Nasdaq futures...

Open article